“The 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: Implications for the Inclusion of Participants in Research vs Diagnosis in Clinical Practice” (2024) Canadian Rheumatology Today, 1(3), pp. 20–25. doi:10.58931/crt.2024.1355.